miR-365a-5p suppresses gefitinib resistance in non-small-cell lung cancer through targeting PELI3

Pharmacogenomics, Ahead of Print.
Source: Future Medicine: Pharmacogenomics - Category: Genetics & Stem Cells Authors: Source Type: research